SG

Sandeep Gulati

Active Director Director DIN 10580373
DIN 10580373 First appointment Apr 2024 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value •••• Premium profile

About Sandeep Gulati

Data last updated:

Sandeep Gulati is a Director at Resmed India Private Limited (since 2024). The company operates in Healthcare. Resmed India Private Limited reported revenue of ₹268 Cr (FY 2025).

DIN 10580373
Primary Designation Director
Industry Healthcare
First Appointment 15 Apr 2024
Oldest Company Age 19 yrs
Largest company Resmed India Private Limited · ₹268 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Resmed India Private Limited U85110DL2007FTC157447
Director15 Apr 20242007₹268 Cr (FY 2025)Active

Board colleagues of Sandeep Gulati

Directorship timeline

Open interactive timeline →
Resmed India Private Limited
Premium access

Shareholding and investment profile for Sandeep Gulati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandeep Gulati

Sandeep Gulati currently holds 1 directorship: Resmed India Private Limited (Director, since 15 Apr 2024, revenue ₹268 Cr (FY 2025)).

Sandeep Gulati was first appointed on 15 Apr 2024 as Director at Resmed India Private Limited.

The current boards of Sandeep Gulati's companies include Ashish Kumar Matta (Resmed India Private Limited), Michael James Rider (Resmed India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available